Form 4: Guardant Health Director Reports Stock Transaction
Insider Transaction (Form 4)
Alex M Azar Ii, a Director of Guardant Health, Inc., reported multiple transactions in common stock on September 12, 2026.
Summary
- Option exercise/conversion: acquired 1,651 Common Stock on September 12, 2026; holds 1,651 after (Direct).
- Option exercise/conversion: disposed of 1,651 Restricted Stock Units on September 12, 2026; holds 4,953 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Alex M Azar Ii — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-12 | Option exercise/conversion | Common Stock | 1,651 | — | — | 1,651 |
| 2026-09-12 | Option exercise/conversion | Restricted Stock Units | 1,651 | — | — | 4,953 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-12 | Option exercise/conversion (1,651 shares) |
| 2026-09-12 | Option exercise/conversion (1,651 shares) |
Keywords
insider transaction, Form 4, GH, Guardant Health, Inc., neutral, Alex M Azar Ii
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.